Mamlouk joined ATC in 1989 and has served in his current role since 2003. In H1 2025, the Kuwait-based group reported $262.7 million in revenue and assets of $1.1 billion. In 2024, ATC introduced advanced surgical robotics for orthopedic and urologic procedures and enabled Kuwait’s first telesurgery, during which a surgeon operated remotely from abroad in real time. The company also expanded its portfolio to support genomic diagnostics through the integration of next-generation sequencing solutions in local laboratories.